Adams Brian

Chief Legal OfficerKymera Therapeutics, Inc. (KYMR) · full profile →Form 4 · filed Sep 4, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$744K
Net Open-Market Flow
-$744K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 4, 2026Sell(S)1K$115.55$140K55K
Sep 4, 2026Sell(S)3K$116.81$353K52K
Sep 4, 2026Sell(S)2K$117.57$251K50K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-383874) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about KYMR insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001193125-26-383874"
Ask your agent
Use Arkolith to summarize insider buying and selling at Kymera Therapeutics, Inc.
over the last 90 days and cite the filings.